Last reviewed · How we verify
Hypoglycemics Oral
Hypoglycemics Oral is a Small molecule drug developed by Seoul National University Bundang Hospital. It is currently FDA-approved. Also known as: Oral antidiabetic medication escalation.
At a glance
| Generic name | Hypoglycemics Oral |
|---|---|
| Also known as | Oral antidiabetic medication escalation |
| Sponsor | Seoul National University Bundang Hospital |
| Modality | Small molecule |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- iGlarLixi CGM Study in Chinese T2D Individuals After OADs (PHASE4)
- A Study Comparing Safety and Efficacy of SHR-3167 Fixed-Dose Titration and Individualized-Dose Titration in Adults With Type 2 Diabetes Inadequately Controlled With Oral Antihyperglycemic Agents (PHASE2)
- Impact of Date Consumption on Metabolic Control and Oxidative Stress in Patients With Type 2 Diabetes (NA)
- Mitochondrial Redox Modulation in Newly Diagnosed Type 2 Diabetes: A Randomized Controlled Trial Comparing Imeglimin vs. Metformin Monotherapy (PHASE4)
- Comparative Study Between (SGLT-2i) and (DPP-4i) in the Prevention of DIC (PHASE4)
- Oral Anti Diabetic Agents in the Hospital (PHASE4)
- Relative Desirability of Metformin vs. Birth Control Pill in Treating PCOS in Women of Later Reproductive Age (EARLY_PHASE1)
- Regimen Transition After Short-Term Intensive Insulin Therapy in Type 2 Diabetes (PHASE4)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Hypoglycemics Oral CI brief — competitive landscape report
- Hypoglycemics Oral updates RSS · CI watch RSS
- Seoul National University Bundang Hospital portfolio CI
Frequently asked questions about Hypoglycemics Oral
What is Hypoglycemics Oral?
Hypoglycemics Oral is a Small molecule drug developed by Seoul National University Bundang Hospital.
Who makes Hypoglycemics Oral?
Hypoglycemics Oral is developed and marketed by Seoul National University Bundang Hospital (see full Seoul National University Bundang Hospital pipeline at /company/seoul-national-university-bundang-hospital).
Is Hypoglycemics Oral also known as anything else?
Hypoglycemics Oral is also known as Oral antidiabetic medication escalation.
What development phase is Hypoglycemics Oral in?
Hypoglycemics Oral is FDA-approved (marketed).
Related
- Manufacturer: Seoul National University Bundang Hospital — full pipeline
- Also known as: Oral antidiabetic medication escalation
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing